by Jenny Ruth
While Southern Cross is within its rights to change the benefits it offers, advisers are complaining about the lack of communication and the shock their clients are experiencing at finding they don't have the cover they thought they did, just at the point when they actually need to cover.
“Whilst they have the right in the policy to change the wording, simply removing this significant benefit without advice is, I suggest, uneithical and could cause many members to be seriously affected,” says Graeme Lindsay, who provides analysis to life and health insurance agents through his firm Strategy Financial Services.
Jon-Paul Hale of Willowgrove Consulting says it is “arrogant of Southern Cross to suggest we have and know all about all the conditions” and that agents should have been aware of the changes.
“This means that their existing policyholders won't get access to treatments they expect and largely have no avenue for retribution with Southern Cross either,” Hale says.
The client who brought the change to his attention had used the benefit extensively in the past for several hospitalisations to treat a drug-resistant e-coli infection in an organ, but hadn't needed it since early 2020 when the affected organ was removed.
“Recently, they have had a change in circumstances and budget concern, so they were looking at their options and noted this benefit wasn't there and called me,” Hale says.
Both Hale and Lindsay provided Good Returns with extensive documentation of material Southern Cross sent policyholders both before and after the changes that appear to show the insurer made those changes in a stealthy manner.
No mention of dropped cover
Advice Southern Cross sent to members in November 2020 after the benefit had been dropped said:
“We're enhancing some benefits and making changes to provide more options,” the notification said.
“So that plans are easier to use, understand and compare, we've made some changes to align and simplify them,” it said.
“There are new cancer cover options for some plans, giving you more choice including access to cancer drugs not subsidised by Pharmac. Cover has been added for the latest proven new health technologies.”
The notification went on detail a number of changes, including a new benefit paying $100 a year for an annual health check, but nowhere does it say the non-surgical hospitalisation benefit had been dropped.
When Lindsay queried Southern Cross about this, the response from the company said: The Wellbeing policy wordings do not have a specific benefit for non-surgical hospitalisation cover as cover for appropriate non-surgical/medical treatments is provided across many other the other benefits within the plan.”
But Lindsay says this represents a significant reduction in cover for existing policyholders who have suffered a condition after taking out their policy and are now unable to replace the cover with another insurer.
This behaviour “smacks of very dodgy practices” and represents “a blatant serious disretgard for the impact on members,” Lindsay says.
Good Returns has asked Southern Cross about this situation and is awaiting its response.
« nib NZ expects its insurance to be resilient in the face of rising cost of living | Southern Cross says it told advisers, policyholders of withdrawn benefit » |
Special Offers
Sign In to add your comment
© Copyright 1997-2025 Tarawera Publishing Ltd. All Rights Reserved
The additional point that needs making here is the whole industry appears to have missed it: advisers, agents, and research companies.
For this level of change to get by so many people for almost three years says more about how it was delivered and communicated than it does for the financial services industry.
Personally, I get through SX policy wordings on a regular basis, and the removal of a fundamental benefit we all consider to be a standard benefit just doesn't cross our minds for it to have disappeared without fair and reasonable notice of the changes.
But it has!
When you consider that private hospital treatment of chemotherapy, radiotherapy, dialysis and many other treatments were initially covered under this benefit, this creates a massive hole in policyholders' perception of coverage. Not to mention trust in their insurer to do the right thing by them.
We don't know what the next "chemo-type" medical development will be, but around one million insured Southern Cross members do not have access to it with the changes made!
For clarity, I do not mean experimental or unapproved treatments here; this is for treatments approved by MedSafe, funded by Pharmac, that are delivered in a hospital setting.
There is no longer coverage for these newer, but very much approved by clinical medicine, treatments on Southern Cross policies!